HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surgical Management of Toxic Megacolon.

AbstractBACKGROUND/AIMS:
Toxic megacolon carries still a substantial mortality and the decision when to per form emergent colectomy needs precise predictors outcome.
METHODOLOGY:
Thirty-two patients with toxic megacolon were identified from a computer database, and their clinical variables were analysed both univariate and multivariate analysis.
RESULTS:
30-day mortality was 16%, being 17% for the patients with Clostridium difficile colitis and 13% for the patients with inflammatory bowel diseases. Diabetes, MPI class II, ASA classes 4-5, increase serum creatinine level, fever over 39 degrees, renal failure, gangrenous bowel and vasopressor requirement significantly associated with in univariate analysis, but only MPI class II and ASA classes 4-5 were independent predictors of mortality. Major complications occurred in 53% of the patients and they associated with respiratory failure, development of shock and vasopressor requirement. Surgical intensive care was needed by the patients who developed respiratory failure, shock or anaemia the hospital treatment was longer in patients with Clostridium difficile colitis.
CONCLUSION:
Development of signs of organ failures or shock are associated with poorer outcome in patients with toxic megacolon and the patients should be urgently operated, when these signs occur.
AuthorsMäkelä Jyrki Tapani, Kiviniemi Heikki Olavi
JournalHepato-gastroenterology (Hepatogastroenterology) Vol. 61 Issue 131 Pg. 638-41 (May 2014) ISSN: 0172-6390 [Print] Greece
PMID26176049 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Colectomy (adverse effects, mortality)
  • Databases, Factual
  • Female
  • Humans
  • Ileostomy (adverse effects, mortality)
  • Logistic Models
  • Male
  • Megacolon, Toxic (complications, diagnosis, mortality, surgery)
  • Middle Aged
  • Multivariate Analysis
  • Postoperative Complications (mortality, therapy)
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: